Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D004806:Ependymoma / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000627:therapeutic use*; D005910:Glioma / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009603:Nitroso Compounds / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D008926:Plicamycin / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D014750:Vincristine; D003520:Cyclophosphamide; D014508:Urea; D008926:Plicamycin; D005472:Fluorouracil; D008727:Methotrexate